Portable POCT Immunofluorescence Analyzer Makes Testing Smarter, Faster and More Efficient
By LabMedica International staff writers Posted on 12 May 2023 |
With existing POCT dry fluorescence methods it can be difficult to meet the accurate and sensitive detection requirements for clinical samples. The new time-resolved fluorescence immunoassay (TRFIA) technology uses time-resolved techniques to measure fluorescence, combines long decay lifetime markers with time-resolved fluorescence, effectively eliminating non-specific fluorescence interference and greatly improving analytical sensitivity. Now, a new time-resolved immunofluorescence analyzer uses TRFIA technology to quantitatively measure the concentration of analytes in blood or other samples at the POC.
The FIA Go from Goldsite Diagnostics Inc. (Shenzhen, China) is a compact fluorescent immunoassay analyzer designed for POCT settings. The rapid, quantitative instrument is based on TRFIA technology for high precision and low interference. The high-performance portable analyzer with a wide-ranging parameter menu provides professionals with high-quality medical information and user-friendly handling.
Featuring easy operation and an Android operating system, the FIA Go analyzer supports multiple tests, including Vitamin D, Ferritin, Folic acid, hormones, thyroid panels, etc. With its one-step operation, the FIA Go analyzer provides fast and accurate results in minutes at the POC, making it suitable for delivering timely primary care at the physician's office. Other flexible application scenarios include clinical laboratories, clinical departments, emergency outpatient clinics, and ambulances.
Related Links:
Goldsite Diagnostics
Latest Molecular Diagnostics News
- Blood Proteins Could Warn of Cancer Seven Years before Diagnosis
- New DNA Origami Technique to Advance Disease Diagnosis
- Ultrasound-Aided Blood Testing Detects Cancer Biomarkers from Cells
- New Respiratory Syndromic Testing Panel Provides Fast and Accurate Results
- New Synthetic Biomarker Technology Differentiates Between Prior Zika and Dengue Infections
- Novel Biomarkers to Improve Diagnosis of Renal Cell Carcinoma Subtypes
- RNA-Powered Molecular Test to Help Combat Early-Age Onset Colorectal Cancer
- Advanced Blood Test to Spot Alzheimer's Before Progression to Dementia
- Multi-Omic Noninvasive Urine-Based DNA Test to Improve Bladder Cancer Detection
- First of Its Kind NGS Assay for Precise Detection of BCR::ABL1 Fusion Gene to Enable Personalized Leukemia Treatment
- Urine Test to Revolutionize Lyme Disease Testing
- Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease
- New Genetic Testing Procedure Combined With Ultrasound Detects High Cardiovascular Risk
- Blood Samples Enhance B-Cell Lymphoma Diagnostics and Prognosis
- Blood Test Predicts Knee Osteoarthritis Eight Years Before Signs Appears On X-Rays
- Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans